This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Rodgers, R.J. Articles by Shepherd, J.K. Search for Related Content PubMed Articles by Rodgers, R.J. Articles by Shepherd, J.K. Social Bookmarking                         What's this?

Effects of an endogenous anxiolytic adrenal steroid, alpha-THDOC, on non-opioid defeat analgesia in male mice: interaction with Ro15-1788

Pharmacoethology Laboratory, School of Psychology, University of Bradford, Bradford BD7 1DP, UK

J.K. Shepherd

Pharmacoethology Laboratory, School of Psychology, University of Bradford, Bradford BD7 1DP, UK

The effects of the putative anxiolytic adrenal steroid, 3, 5-tetrahydro deoxycorticosterone (-THDOC), on non-opioid defeat analgesia in male mice were examined. Although devoid of intrinsic activity on the tail-flick assay, 5 mg/kg -THDOC was found to significantly attenuate the analgesic consequences of defeat experience; lower (2.5 mg/kg) and higher (10-20 mg/kg) doses were ineffective. The ß-isomer of THDOC also significantly reduced defeat analgesia, but only at the highest dose tested (20 mg/kg). Control experiments demonstrated that 5 per cent ethanol, which was employed as a vehicle for the steroids, was without effect per se on basal nociception and, over the limited dose range of 5-10 per cent, did not alter defeat analgesia. Finally, the benzodiazepine receptor antagonist, Ro15-1788 (5 mg/kg) failed to influence the inhibitory effects of either THDOC isomer. Results are discussed in relation to the potential modulation of this form of adaptive pain inhibition by adrenal steroids which influence the GABA receptor-coupled chloride ionophore.

Journal of Psychopharmacology, Vol. 2, No. 3-4, 150-158 (1988)
DOI: 10.1177/026988118800200304


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?